Patents Assigned to Tensive Controls, Inc.
  • Anti-microbial peptides
    Patent number: 10954271
    Abstract: Described herein are anti-microbial peptides having enhanced activity and transport.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: March 23, 2021
    Assignee: Tensive Controls, Inc.
    Inventor: Kenneth Allen Gruber
  • Angiotensin (1-7) analogs and methods relating thereto
    Patent number: 10829519
    Abstract: Angiotensin (1-7) analogs are provided. Also provided are methods of making such analogs methods for using analogs as therapeutic compositions such as, for example, treatment cancer.
    Type: Grant
    Filed: September 16, 2016
    Date of Patent: November 10, 2020
    Assignees: WAKE FOREST UNIVERSITY HEALTH SCIENCES, TENSIVE CONTROLS, INC.
    Inventors: Patricia Gallagher, Ann Tallant, Daniel Yohannes, Kenneth A. Gruber
  • ANGIOTENSIN (1-7) ANALOGS AND METHODS RELATING THERETO
    Publication number: 20190241616
    Abstract: Angiotensin (1-7) analogs are provided. Also provided are methods of making such analogs methods for using analogs as therapeutic compositions such as, for example, treatment cancer.
    Type: Application
    Filed: September 16, 2016
    Publication date: August 8, 2019
    Applicants: WAKE FOREST UNIVERSITY HEALTH SCIENCES, TENSIVE CONTROLS, INC.
    Inventors: PATRICIA GALLAGHER, ANN TALLANT, DANIEL YOHANNES, KENNETH A. GRUBER
  • Anti-microbial peptides
    Patent number: 10351599
    Abstract: Described herein are anti-microbial peptides having enhanced activity and transport.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: July 16, 2019
    Assignee: Tensive Controls, Inc.
    Inventor: Kenneth Allen Gruber
  • Melanocortin analogs having enhanced activity and transport
    Patent number: 9534018
    Abstract: Described herein are melanocortin analogs having enhanced activity and transport.
    Type: Grant
    Filed: March 12, 2013
    Date of Patent: January 3, 2017
    Assignee: TENSIVE CONTROLS INC.
    Inventor: Kenneth Allen Gruber
  • Stabilized melanocortin ligands
    Patent number: 8541545
    Abstract: Compositions and methods are disclosed for a non-naturally occurring melanocortin ligand comprised of a melanocortin analog coupled to a degradation-resistant C-terminal extension and, optionally, an N-terminal extension, to produce a stable melanocortin ligand having diminished or abolished cardiovascular activity while retaining desired melanocortin regulatory activity.
    Type: Grant
    Filed: August 30, 2010
    Date of Patent: September 24, 2013
    Assignee: Tensive Controls Inc.
    Inventor: Kenneth A. Gruber
  • Stablized Melanocortin Ligands
    Publication number: 20120220525
    Abstract: Compositions and methods are disclosed for a non-naturally occurring melanocortin ligand comprised of a melanocortin analog coupled to a degradation-resistant C-terminal extension and, optionally, an N-terminal extension, to produce a stable melanocortin ligand having diminished or abolished cardiovascular activity while retaining desired melanocortin regulatory activity.
    Type: Application
    Filed: August 30, 2010
    Publication date: August 30, 2012
    Applicant: Tensive Controls, Inc.
    Inventor: Kenneth A. Gruber